Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III study of multiple allergen skin prick test solutions
CTR20200810Phase 3Completed
- Sponsor
- Wolwo Biotech
- Start
- May 2020
- Modality
- Small Molecules, Subcutaneous Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics, Sublingual Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of plane tree pollen skin prick solution, dog dander skin prick solution, cat dander skin prick solution, German cockroach skin prick solution, Ragweed pollen extract in allergic rhinitis (AR), allergic conjunctivitis (AC), allergy, Allergen sensitization, sponsored by Wolwo Biotech. Started May 2020; status: completed.
02
Drugs
plane tree pollen skin prick solutiondog dander skin prick solutioncat dander skin prick solutionGerman cockroach skin prick solutionRagweed pollen extract
03
Conditions
allergic rhinitis (AR)allergic conjunctivitis (AC)allergyAllergen sensitization
Beyond the preview
Go deeper on CTR20200810.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20200810.